Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-040-1 | CAS number: 114-07-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- June and July 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Limit dose study (5000 mg/kg) conducted to GLP. Study was conducted following a standard protocol and in accordance with GLP. The study material is well characterized. supporting study only.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- GLP compliance:
- yes
- Test type:
- other: Limit dose study
Test material
- Reference substance name:
- Erythromycin
- EC Number:
- 204-040-1
- EC Name:
- Erythromycin
- Cas Number:
- 114-07-8
- Molecular formula:
- C37H67NO13
- IUPAC Name:
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
Constituent 1
Test animals
- Species:
- other: Mice and rats
- Strain:
- other: ICR mice and Crl:Co®(SD)BR rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female ICR mice weighing 18 to 26 g each (approximately 5 to 6 weeks old) and male and female Crl:co®(SD)BRRats 4 weighing 107 to 135 g each (approximately 5 to 6 weeks old) were used. Following treatment the mice and rats were housed in stainless steel cages with one rat or five mice of the same sex per cage.Ambient temperature was monitored during the study and was
maintained at approximately 71 to 75°F.5 Certified Rodent Chow® #50026 and tap water
were provided ad libitum. Routine and special analyses were conducted on feed and water to assu re that contaminants were not present at levels which would compromise the interpretation of this s tudy. No potential contaminants were identified which could have been expected to affect the study outcome . The cages, cage racks and animal room were kept clean throughout the study.
The animals were allowed to acclimatize to the animal care facilities for 6 or 7 days before treatment. Food was withheld from the mice for a period of 30-60 minutes and rats were fasted overnight before
treatment.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: hydroxypropylmethylcellulose
- Details on oral exposure:
- dose level: 5000 mg/kg (5 g/kg)
concentration: 20 ml/kg - Doses:
- The test suspension was administered one time by gavage to all animals at a dose of 20 ml/kg (5 g A BBOTT-56268/kg); this was considered the maximum volume that could be administered to mice and rats as a single treatment.
- No. of animals per sex per dose:
- 5 females/males per dose rats and mice
- Control animals:
- yes
- Details on study design:
- All animals were observed frequently on the day of treatment and at least once daily for the following two weeks for fatalities and for signs of toxicity . All animals were weighed weekly.
At the end of the observation period the animals were killed by ascending concentrations of carbon dioxide. All animals were subjected to gross pathological observations. . No tissues were retained.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: rats
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: mice
- Mortality:
- Mice exhibited no signs of toxicity and none of the mice died. One male rat was found dead 5 days after treatment.
- Clinical signs:
- other: Decreased activity was observed in the rats at approximately four hours after treatment, but the rats appeared normal later the same day. Increased amounts of loose hair were observed beneath the cages of the rats 6-8 days after treatment
- Gross pathology:
- Necropsy of the rat that died revealed only that the rat was dehydrated. Dilatation of the renal pelvis was found in one male rat when the remaining mice and rats were killed and necropsied two weeks after treatment. No other gross morphologic changes were found.
- Other findings:
- ABBOTT-56268 was practically non-toxic to mice and rats. Mice exhibited no adverse effects and
rats generally exhibited only mild effects (e.g., decreased activity, hair loss and slightly reduced body weight gains) following treatment with the largest dose that could be administered, 5 g/kg. The death of one rat occurred 5 days after treatment and, therefore, may not have been related to treatment with ABBOTT-56268. Dilatation of the renal pelvis of one rat killed two weeks after treatment was not considered drug-related.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The acute oral median lethal dose (LD50) of the test material was 5 g/kg.
ABBOTT-56268 was practically non-toxic to mice and rats. Mice exhibited no adverse effects and ra ts generally exhibited only mild effects (e.g., decreased activity, hair loss and slightly reduced body weight gains) following treatment with the largest dose that could be administered, 5 g/kg. The death of one rat occurred 5 days after treatment and, therefore, may not have been related to treatment wi th ABBOTT-56268. Dilatation of the renal pelvis of one rat killed two weeks after treatment was not considered drug-related.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.